Hormone replacement therapy and tumour grade in breast cancer: Prospective study in screening unit

British Medical Journal

Volumn 312, Issue 7047, 1996, Pages 1646-1647

  Harding, Claudia ^a   Knox, W F ^a   Faragher, E B ^a   Baildam, A ^a   Bundred, N J ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER SCREENING; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0029987270     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7047.1646     Document Type: Article

References (5)

1. Hunt K, Vessey M, McPherson K. Long term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol 1987;94:620-35.
2. Gambrell RD. Update on hormone replacement therapy. Am Fam Physician 1992;46:87-96S.
3. Colditz G, Hankinson SE, Hunter J, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
4. Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, et al. A prognostic index in primary breast cancer. Br J Cancer 1982;45:361-366.
5. Bergvist L, Adami HO, Persson I, Bergstrom R, Krusemo UB. Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progesterone replacement therapy. Am J Epidemiol 1989;130:221-8.